2/13
06:41 pm
alt
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $20.00 price target on the stock.
Medium
Report
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $20.00 price target on the stock.
2/13
06:41 pm
alt
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $20.00 price target on the stock.
Medium
Report
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $20.00 price target on the stock.